BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8807113)

  • 1. Immunotherapy of respiratory syncytial virus pneumonia following bone marrow transplantation.
    De Vincenzo JP; Leombruno D; Soiffer RJ; Siber GR
    Bone Marrow Transplant; 1996 Jun; 17(6):1051-6. PubMed ID: 8807113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience.
    DeVincenzo JP; Hirsch RL; Fuentes RJ; Top FH
    Bone Marrow Transplant; 2000 Jan; 25(2):161-5. PubMed ID: 10673674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.
    Whimbey E; Champlin RE; Englund JA; Mirza NQ; Piedra PA; Goodrich JM; Przepiorka D; Luna MA; Morice RC; Neumann JL
    Bone Marrow Transplant; 1995 Sep; 16(3):393-9. PubMed ID: 8535312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin.
    Ghosh S; Champlin RE; Englund J; Giralt SA; Rolston K; Raad I; Jacobson K; Neumann J; Ippoliti C; Mallik S; Whimbey E
    Bone Marrow Transplant; 2000 Apr; 25(7):751-5. PubMed ID: 10745261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An outbreak of respiratory syncytial virus infection in a bone marrow transplant unit: effect on engraftment and outcome of pneumonia without specific antiviral treatment.
    Abdallah A; Rowland KE; Schepetiuk SK; To LB; Bardy P
    Bone Marrow Transplant; 2003 Jul; 32(2):195-203. PubMed ID: 12838285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections.
    Sparrelid E; Ljungman P; Ekelöf-Andström E; Aschan J; Ringdén O; Winiarski J; Wåhlin B; Andersson J
    Bone Marrow Transplant; 1997 May; 19(9):905-8. PubMed ID: 9156264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory syncytial virus infection following hematopoietic stem cell transplantation.
    Small TN; Casson A; Malak SF; Boulad F; Kiehn TE; Stiles J; Ushay HM; Sepkowitz KA
    Bone Marrow Transplant; 2002 Feb; 29(4):321-7. PubMed ID: 11896429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of respiratory syncytial virus pneumonia in a lung transplant recipient: case report and review of the literature.
    Flynn JD; Akers WS; Jones M; Stevkovic N; Waid T; Mullett T; Jahania S
    Pharmacotherapy; 2004 Jul; 24(7):932-8. PubMed ID: 15303457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and review.
    Khushalani NI; Bakri FG; Wentling D; Brown K; Mohr A; Anderson B; Keesler C; Ball D; Bernstein ZP; Bernstein SH; Czuczman MS; Segal BH; McCarthy PL
    Bone Marrow Transplant; 2001 May; 27(10):1071-3. PubMed ID: 11438823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor lymphocyte infusion for treatment of life-threatening respiratory syncytial virus infection following bone marrow transplantation.
    Kishi Y; Kami M; Oki Y; Kazuyama Y; Kawabata M; Miyakoshi S; Morinaga S; Suzuki R; Mori S; Muto Y
    Bone Marrow Transplant; 2000 Sep; 26(5):573-6. PubMed ID: 11019850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory syncytial virus infection outbreak among pediatric patients with oncologic diseases and/or BMT.
    Anak S; Atay D; Unuvar A; Garipardic M; Agaoglu L; Ozturk G; Karakas Z; Devecioglu O
    Pediatr Pulmonol; 2010 Mar; 45(3):307-11. PubMed ID: 20146398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful therapy with ribavirin of late onset respiratory syncytial virus pneumonitis complicating allogeneic bone transplantation.
    Win N; Mitchell D; Pugh S; Russell NH
    Clin Lab Haematol; 1992; 14(1):29-32. PubMed ID: 1600691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nosocomial respiratory syncytial virus infections in three cases in a bone marrow transplantation unit].
    Kalayoglu Beşişik S; Sen F; Midilli K; Yilmaz G; Ozsüt H; Calangu S; Sargin D
    Mikrobiyol Bul; 2008 Apr; 42(2):359-64. PubMed ID: 18697436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins.
    Ghosh S; Champlin RE; Ueno NT; Anderlini P; Rolston K; Raad I; Kontoyiannis D; Jacobson K; Luna M; Tarrand J; Whimbey E
    Bone Marrow Transplant; 2001 Aug; 28(3):271-5. PubMed ID: 11535995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of respiratory syncytial virus infections in immunocompromised hematological patients].
    Thorsen S; Hornsleth AK; Pedersen BK; Heilmann CJ
    Ugeskr Laeger; 2000 Aug; 162(35):4644-7. PubMed ID: 10986889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients.
    Hynicka LM; Ensor CR
    Ann Pharmacother; 2012 Apr; 46(4):558-66. PubMed ID: 22395247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe respiratory syncytial virus pneumonia after autologous bone marrow transplantation: a report of three cases and review.
    Fouillard L; Mouthon L; Laporte JP; Isnard F; Stachowiak J; Aoudjhane M; Lucet JC; Wolf M; Bricourt F; Douay L
    Bone Marrow Transplant; 1992 Feb; 9(2):97-100. PubMed ID: 1571714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.
    Chakrabarti S; Collingham KE; Holder K; Fegan CD; Osman H; Milligan DW
    Bone Marrow Transplant; 2001 Oct; 28(8):759-63. PubMed ID: 11781627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.
    Glanville AR; Scott AI; Morton JM; Aboyoun CL; Plit ML; Carter IW; Malouf MA
    J Heart Lung Transplant; 2005 Dec; 24(12):2114-9. PubMed ID: 16364859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-emptive use of aerosolized ribavirin in the treatment of asymptomatic pediatric marrow transplant patients testing positive for RSV.
    Adams R; Christenson J; Petersen F; Beatty P
    Bone Marrow Transplant; 1999 Sep; 24(6):661-4. PubMed ID: 10490733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.